Literature DB >> 8386184

Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.

S J Heydrick1, D Jullien, N Gautier, J F Tanti, S Giorgetti, E Van Obberghen, Y Le Marchand-Brustel.   

Abstract

Activation of phosphatidylinositol-3-kinase (PI3K) is one of the earliest postreceptor events in the insulin signaling pathway. Incubation of soleus muscles from lean mice with 50 nM insulin caused a 3-10-fold increase in antiphosphotyrosine-immunoprecipitable PI3K (antiPTyr-PI3K) activity within 2 min in muscle homogenates as well as both the cytosolic and membrane fractions. Insulin did not affect total PI3K activity. Both the antiPTyr-PI3K stimulation and activation of insulin receptor tyrosine kinase were dependent on hormone concentration. In muscles from obese, insulin-resistant mice, there was a 40-60% decrease in antiPTyr-PI3K activity after 2 min of insulin that was present equally in the cytosolic and membrane fractions. A significant reduction in insulin sensitivity was also observed. The defect appears to result from alterations in both insulin receptor and postreceptor signaling. Starvation of obese mice for 48 h, which is known to reverse insulin resistance, normalized the insulin response of both PI3K and the receptor tyrosine kinase. The results demonstrate that: (a) antiPTyr-PI3K activity is responsive to insulin in mouse skeletal muscle, (b) both the insulin responsiveness and sensitivity of this activity are blunted in insulin-resistant muscles from obese mice, (c) these alterations result from a combination of insulin receptor and postreceptor defects, and (d) starvation restores normal insulin responses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386184      PMCID: PMC288107          DOI: 10.1172/JCI116337

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase.

Authors:  P L Rothenberg; W S Lane; A Karasik; J Backer; M White; C R Kahn
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

2.  Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans.

Authors:  M C McGuire; R M Fields; B L Nyomba; I Raz; C Bogardus; N K Tonks; J Sommercorn
Journal:  Diabetes       Date:  1991-07       Impact factor: 9.461

3.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.

Authors:  X J Sun; P Rothenberg; C R Kahn; J M Backer; E Araki; P A Wilden; D A Cahill; B J Goldstein; M F White
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

4.  cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.

Authors:  J A Escobedo; S Navankasattusas; W M Kavanaugh; D Milfay; V A Fried; L T Williams
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

Review 5.  Phosphoinositide kinases.

Authors:  C L Carpenter; L C Cantley
Journal:  Biochemistry       Date:  1990-12-25       Impact factor: 3.162

6.  Antiphosphotyrosine antibodies modulate insulin receptor kinase activity and insulin action.

Authors:  R Ballotti; J C Scimeca; A Kowalski; E Van Obberghen
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

7.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Authors:  M Otsu; I Hiles; I Gout; M J Fry; F Ruiz-Larrea; G Panayotou; A Thompson; R Dhand; J Hsuan; N Totty
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

8.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

Authors:  E Y Skolnik; B Margolis; M Mohammadi; E Lowenstein; R Fischer; A Drepps; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

9.  Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle.

Authors:  J F Tanti; T Grémeaux; E Van Obberghen; Y Le Marchand-Brustel
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

10.  A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor.

Authors:  G G Choudhury; L M Wang; J Pierce; S A Harvey; A Y Sakaguchi
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

View more
  26 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active phosphatidylinositol 3-kinase and protein kinase B.

Authors:  M Cormont; N Gautier; K Ilc; Y le Marchand-Brustel
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

3.  Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.

Authors:  Kazuaki Miyake; Wataru Ogawa; Michihiro Matsumoto; Takehiro Nakamura; Hiroshi Sakaue; Masato Kasuga
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

5.  Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Authors:  Claude Knauf; Patrice D Cani; Christophe Perrin; Miguel A Iglesias; Jean François Maury; Elodie Bernard; Fadilha Benhamed; Thierry Grémeaux; Daniel J Drucker; C Ronald Kahn; Jean Girard; Jean François Tanti; Nathalie M Delzenne; Catherine Postic; Rémy Burcelin
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage.

Authors:  Frédéric Bost; Leslie Caron; Irène Marchetti; Christian Dani; Yannick Le Marchand-Brustel; Bernard Binétruy
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

7.  Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats.

Authors:  Jun Li; Tao Chen; Kun Li; Hongtao Yan; Xiaowei Li; Yun Yang; Yulan Zhang; Bingyin Su; Fuxiang Li
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

8.  Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking.

Authors:  G A Yudowski; R Efendiev; C H Pedemonte; A I Katz; P O Berggren; A M Bertorello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 9.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor.

Authors:  E Van Obberghen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

10.  Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle.

Authors:  A E Stenbit; R Burcelin; E B Katz; T S Tsao; N Gautier; M J Charron; Y Le Marchand-Brustel
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.